KalypsiWho covers the storyBeta
SearchΕλληνικάThe edition by email
← StoriesHealthFirst published 20 October at 11:01, Zougla

New treatment for pancreatic cancer gains access in Greece

3 outlets · 3 articles
Who covers itEach circle is an outlet that covered the story, placed at its published political lean; the letters are its initials. 2 of the 3 outlets have a published lean.
Far leftFar LLeftLeftCentre-leftC-LCentreCtrCentre-rightC-RRightRightFar rightFar R
Which outlet each circle is
  • Zougla Centre-right
  • Newsbeast Centre-right
  • Haravgi / Dialogos not rated
No published lean (1)

What is happening

What the sources report

The recommendations do not constitute final approvals, as decisions of the European Commission follow. Haravgi / Dialogos

Among them is Rasonque, with the active substance daraxonrasib, for adults with metastatic pancreatic adenocarcinoma who have already received treatment. Haravgi / Dialogos

Foundayo, with the active substance orforglipron, also received a positive opinion, for adults with obesity or overweight and for patients with inadequately controlled type 2 diabetes. Haravgi / Dialogos

Daraxonrasib received approval from the American FDA on 26 August 2026. Zougla

Where they differ

Haravgi / Dialogos reports that in the phase three study with 500 patients, median overall survival with the drug was 12.4 months, compared with 6.7 months with chemotherapy, while Zougla reports that median overall survival was 13.2 months with daraxonrasib, compared with 6.7 months with chemotherapy. Zougla Haravgi / Dialogos

Summary by artificial intelligence (Claude) based on 2 articles. It may contain errors; please check the sources.

Spotted an error?

The editor reads it. The email is deleted as soon as the report is closed.

How each side headlined it

Each outlet's first headline, by its published political lean. The method

Left 0

No outlet from this side.

Centre 0

No outlet from this side.

Right 2
Headlines from 1 outlet without a political rating
All articles by time (3)
TimeOutletHeadline
20 Oct, 11:01ZouglaΚαινοτόμος θεραπεία για τον καρκίνο του παγκρέατος: Πρόσβαση για τους ασθενείς και στην Ελλάδα
20 Oct, 21:49NewsbeastΚαρκίνος του παγκρέατος: Νέα θεραπεία σχεδόν διπλασιάζει την επιβίωση – Οι πρώτοι ασθενείς στην Ελλάδα αποκτούν πρόσβαση Text republished from Zougla
21 Oct, 09:38Haravgi / DialogosEMA: Θετική εισήγηση για χάπι κατά της παχυσαρκίας και νέα θεραπεία για τον καρκίνο του παγκρέατος

When each outlet covered it

First report 20 October at 11:01, latest 21 October at 09:38. Within the first hour: 1 of 3 outlets. Each column: 1 hour.